CJC-1295 (No DAC) + Ipamorelin 10mg

A dual-peptide formulation combining a GHRH analog with a growth hormone secretagogue, studied in endocrine signaling research.

Research Overview
This combination is examined in laboratory settings for its interaction with growth hormone regulatory pathways, involving both pituitary signaling and receptor activation.

How It’s Studied (Plain Language)
Researchers use this combination to observe how different signaling pathways work together to regulate hormone-related processes. One peptide signals the system, while the other supports receptor-level interaction, allowing for more complex pathway analysis.

Key Characteristics

• Dual peptide formulation
• Studied in endocrine pathway research
• Complementary signaling mechanisms

Specifications

• 3ml multi-use vial
• Lyophilized powder
• Purity ≥99%
• Third-party tested

For research purposes only. Not for human consumption. This product is intended solely for use in laboratory and scientific research settings. RR Peptides does not condone the use of this product outside of a controlled research environment.